From fertility-sparing treatment to live birth: an IVF-based cohort study of endometrial neoplasia

Background Fertility-sparing treatment allows selected patients with endometrial intraepithelial neoplasia (EIN) or early endometrioid endometrial carcinoma to preserve reproductive potential, but reported pregnancy and live-birth rates depend strongly on the denominator used. We evaluated the pathway from conservative treatment to embryo transfer and live birth and explored factors associated with IVF outcomes. Methods This retrospective single-center cohort included patients evaluated at Acıbadem Maslak Hospital, Istanbul, Türkiye, between 2016 and 2026. The primary cohort comprised patients with EIN or grade 1 endometrioid carcinoma without documented myometrial invasion who entered a fertility-sparing pathway. Conservative treatment included megestrol acetate, a levonorgestrel-releasing intrauterine system (LNG-IUS), or both. Outcomes were reported using explicit clinical denominators. Exact binomial confidence intervals, effect estimates, and false-discovery-rate-adjusted q values were used. Results Among 44 patients, 40 entered the primary fertility-sparing pathway and 21 reached their first analyzed embryo transfer. Positive β -hCG occurred in 12 of 21 transferred patients (57.1%). Of these, 9 achieved live birth, one pregnancy was ongoing at the study data cutoff, and two resulted in biochemical pregnancy loss. Live birth occurred in 42.9% of patients reaching their first analyzed transfer and had been achieved in 22.5% of the primary cohort by the data cutoff. Younger age, higher antral follicle count, and greater oocyte yield were associated with live birth in exploratory analyses. No statistically significant association was observed between reproductive outcomes and LNG-IUS exposure or diagnosis-to-transfer timing. High-grade histological progression was documented in 3 of 40 patients during available follow-up. One patient subsequently underwent hysterectomy, while the remaining two underwent definitive surgical treatment following progression to higher grade disease detected during surveillance. Conclusions Reproductive success after fertility-sparing treatment is best interpreted as a multistage pathway. Accordingly, the cohort-level live birth proportion at the study data cutoff should not be interpreted as a final cumulative live-birth probability, because some patients remained within the reproductive pathway and had not yet completed fertility treatment. The associations between live birth and factors such as age, ovarian reserve, oocyte yield, transfer stage, conservative-treatment choice, and diagnosis-to-transfer timing require confirmation in larger prospective cohorts with complete longitudinal follow-up.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-17
DOI
https://doi.org/10.3389/fmed.2026.1967411
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From fertility-sparing treatment to live birth: an IVF-based cohort study of endometrial neoplasia

Ayşen Yücetürk, Burak Elmas, Bülent Tıraş, Özge Karaosmanoğlu et al.
3 links
Frontiers in Medicine
Endometrial and Cervical Cancer Treatments
article

From fertility-sparing treatment to live birth: an IVF-based cohort study of endometrial neoplasia

Ayşen Yücetürk, Burak Elmas, Bülent Tıraş, Özge Karaosmanoğlu, İlke Özer Aslan, Nuri Peker
article en

Abstract

Background Fertility-sparing treatment allows selected patients with endometrial intraepithelial neoplasia (EIN) or early endometrioid endometrial carcinoma to preserve reproductive potential, but reported pregnancy and live-birth rates depend strongly on the denominator used. We evaluated the pathway from conservative treatment to embryo transfer and live birth and explored factors associated with IVF outcomes. Methods This retrospective single-center cohort included patients evaluated at Acıbadem Maslak Hospital, Istanbul, Türkiye, between 2016 and 2026. The primary cohort comprised patients with EIN or grade 1 endometrioid carcinoma without documented myometrial invasion who entered a fertility-sparing pathway. Conservative treatment included megestrol acetate, a levonorgestrel-releasing intrauterine system (LNG-IUS), or both. Outcomes were reported using explicit clinical denominators. Exact binomial confidence intervals, effect estimates, and false-discovery-rate-adjusted q values were used. Results Among 44 patients, 40 entered the primary fertility-sparing pathway and 21 reached their first analyzed embryo transfer. Positive β -hCG occurred in 12 of 21 transferred patients (57.1%). Of these, 9 achieved live birth, one pregnancy was ongoing at the study data cutoff, and two resulted in biochemical pregnancy loss. Live birth occurred in 42.9% of patients reaching their first analyzed transfer and had been achieved in 22.5% of the primary cohort by the data cutoff. Younger age, higher antral follicle count, and greater oocyte yield were associated with live birth in exploratory analyses. No statistically significant association was observed between reproductive outcomes and LNG-IUS exposure or diagnosis-to-transfer timing. High-grade histological progression was documented in 3 of 40 patients during available follow-up. One patient subsequently underwent hysterectomy, while the remaining two underwent definitive surgical treatment following progression to higher grade disease detected during surveillance. Conclusions Reproductive success after fertility-sparing treatment is best interpreted as a multistage pathway. Accordingly, the cohort-level live birth proportion at the study data cutoff should not be interpreted as a final cumulative live-birth probability, because some patients remained within the reproductive pathway and had not yet completed fertility treatment. The associations between live birth and factors such as age, ovarian reserve, oocyte yield, transfer stage, conservative-treatment choice, and diagnosis-to-transfer timing require confirmation in larger prospective cohorts with complete longitudinal follow-up.

Frontiers in MedicineVol. 13
Acıbadem University (TR)
Good health and well-being
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon